References
1. Torre, L.A., et al., Global cancer statistics, 2012. CA Cancer
J Clin, 2015. 65 (2): p. 87-108.
2. Global, regional, and national age-sex specific all-cause and
cause-specific mortality for 240 causes of death, 1990-2013: a
systematic analysis for the Global Burden of Disease Study 2013.Lancet, 2015. 385 (9963): p. 117-71.
3. Rahbari, N.N., et al., Hepatocellular carcinoma: current
management and perspectives for the future. Ann Surg, 2011.253 (3): p. 453-69.
4. Sugawara, Y. and N. Kokudo, Surgical treatment of
hepatocellular carcinoma: comparison of resection and transplantation.Oncology, 2008. 75 Suppl 1 : p. 119-23.
5. Zheng, Z., et al., Adjuvant chemotherapy for patients with
primary hepatocellular carcinoma: a meta-analysis. Int J Cancer, 2015.136 (6): p. E751-9.
6. Farber, H.W. and J. Loscalzo, Mechanism of disease: Pulmonary
hypertension. Discov Med, 2005. 5 (25): p. 80-7.
7. Aydin, S., et al., A comprehensive immunohistochemical
examination of the distribution of the fat-burning protein irisin in
biological tissues. Peptides, 2014. 61 : p. 130-6.
8. Lim, L.P., et al., Vertebrate microRNA genes. Science, 2003.299 (5612): p. 1540.
9. Ason, B., et al., Differences in vertebrate microRNA
expression. Proc Natl Acad Sci U S A, 2006. 103 (39): p.
14385-9.
10. Schaefer, A., et al., Diagnostic and prognostic implications
of microRNA profiling in prostate carcinoma. Int J Cancer, 2010.126 (5): p. 1166-76.
11. Sempere, L.F., et al., Altered MicroRNA expression confined to
specific epithelial cell subpopulations in breast cancer. Cancer Res,
2007. 67 (24): p. 11612-20.
12. Markou, A., et al., Prognostic value of mature microRNA-21 and
microRNA-205 overexpression in non-small cell lung cancer by
quantitative real-time RT-PCR. Clin Chem, 2008. 54 (10): p.
1696-704.
13. Dar, A.A., et al., miRNA-205 suppresses melanoma cell
proliferation and induces senescence via regulation of E2F1 protein. J
Biol Chem, 2011. 286 (19): p. 16606-14.
14. Fletcher, A.M., A.C. Heaford, and D.K. Trask, Detection of
metastatic head and neck squamous cell carcinoma using the relative
expression of tissue-specific mir-205. Transl Oncol, 2008.1 (4): p. 202-8.
15. Cai, J., et al., miR-205 targets PTEN and PHLPP2 to augment
AKT signaling and drive malignant phenotypes in non-small cell lung
cancer. Cancer Res, 2013. 73 (17): p. 5402-15.
16. Karaayvaz, M., et al., Prognostic significance of miR-205 in
endometrial cancer. PLoS One, 2012. 7 (4): p. e35158.
17. Li, C., et al., CD105 prevents apoptosis in hypoxic
endothelial cells. J Cell Sci, 2003. 116 (Pt 13): p. 2677-85.
18. Ricci-Vitiani, L., et al., Tumour vascularization via
endothelial differentiation of glioblastoma stem-like cells. Nature,
2010. 468 (7325): p. 824-8.
19. Wang, R., et al., Glioblastoma stem-like cells give rise to
tumour endothelium. Nature, 2010. 468 (7325): p. 829-33.
20. Miller, D.W., et al., Elevated expression of endoglin, a
component of the TGF-beta-receptor complex, correlates with
proliferation of tumor endothelial cells. Int J Cancer, 1999.81 (4): p. 568-72.
21. Su, T., et al., Deletion of histidine triad nucleotide-binding
protein 1/PKC-interacting protein in mice enhances cell growth and
carcinogenesis. Proc Natl Acad Sci U S A, 2003. 100 (13): p.
7824-9.
22. Li, H., et al., Hint1 is a haplo-insufficient tumor suppressor
in mice. Oncogene, 2006. 25 (5): p. 713-21.
23. Ayuso, C., et al., Diagnosis and staging of hepatocellular
carcinoma (HCC): current guidelines. Eur J Radiol, 2018. 101 :
p. 72-81.
24. Livak, K.J. and T.D. Schmittgen, Analysis of relative gene
expression data using real-time quantitative PCR and the 2(-Delta Delta
C(T)) Method. Methods, 2001. 25 (4): p. 402-8.
25. Reddy, K.B., MicroRNA (miRNA) in cancer. Cancer Cell Int,
2015. 15 : p. 38.
26. Wang, L., et al., HINT1 inhibits beta-catenin/TCF4, USF2 and
NFkappaB activity in human hepatoma cells. Int J Cancer, 2009.124 (7): p. 1526-34.
27. Ishizaki, Y., et al., Immunohistochemical analysis and
mutational analyses of beta-catenin, Axin family and APC genes in
hepatocellular carcinomas. Int J Oncol, 2004. 24 (5): p.
1077-83.
28. Jamora, C. and E. Fuchs, Intercellular adhesion, signalling
and the cytoskeleton. Nat Cell Biol, 2002. 4 (4): p. E101-8.
29. Waisberg, J. and G.T. Saba, Wnt-/-β-catenin pathway signaling
in human hepatocellular carcinoma. World J Hepatol, 2015.7 (26): p. 2631-5.
30. Li, J., et al., Alterations of axis inhibition protein 1
(AXIN1) in hepatitis B virus-related hepatocellular carcinoma and
overexpression of AXIN1 induces apoptosis in hepatocellular cancer
cells. Oncol Res, 2013. 20 (7): p. 281-8.
31. Acunzo, M., et al., MicroRNA and cancer–a brief overview.Adv Biol Regul, 2015. 57 : p. 1-9.
32. El-Awady, R.A., et al., Epigenetics and miRNA as predictive
markers and targets for lung cancer chemotherapy. Cancer Biol Ther,
2015. 16 (7): p. 1056-70.
33. Markou, A., M. Zavridou, and E.S. Lianidou, miRNA-21 as a
novel therapeutic target in lung cancer. Lung Cancer (Auckl), 2016.7 : p. 19-27.
34. Nana-Sinkam, S.P. and C.M. Croce, Clinical applications for
microRNAs in cancer. Clin Pharmacol Ther, 2013. 93 (1): p.
98-104.
35. Wang, M., et al., Subcellular Targets of Zinc Oxide
Nanoparticles During the Aging Process: Role of Cross-talk Between
Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in the
Genotoxic Response. Toxicol Sci, 2019. 171 (1): p. 159-171.
36. Mazur-Bialy, A.I., Irisin acts as a regulator of macrophages
host defense. Life Sci, 2017. 176 : p. 21-25.
37. Park, D.W., et al., GSK3β-dependent inhibition of AMPK
potentiates activation of neutrophils and macrophages and enhances
severity of acute lung injury. Am J Physiol Lung Cell Mol Physiol,
2014. 307 (10): p. L735-45.
38. Batty, D., et al., Stable binding of human XPC complex to
irradiated DNA confers strong discrimination for damaged sites. J Mol
Biol, 2000. 300 (2): p. 275-90.
39. Hanna, J.A., et al., In situ measurement of miR-205 in
malignant melanoma tissue supports its role as a tumor suppressor
microRNA. Lab Invest, 2012. 92 (10): p. 1390-7.
40. Rubenfeld, G.D., et al., Incidence and outcomes of acute lung
injury. N Engl J Med, 2005. 353 (16): p. 1685-93.
41. Niu, K., et al., MiR-205 promotes motility of ovarian cancer
cells via targeting ZEB1. Gene, 2015. 574 (2): p. 330-6.
42. Zou, L., et al., Down-regulated PLAC8 promotes hepatocellular
carcinoma cell proliferation by enhancing PI3K/Akt/GSK3β/Wnt/β-catenin
signaling. Biomed Pharmacother, 2016. 84: p. 139-146.
43. Zeid, D., et al., Terc Gene Cluster Variants Predict Liver Telomere
Length in Mice. Cells, 2021. 10(10).
44. Li, Y., et al., Identification of serum CCL15 in hepatocellular
carcinoma. Br J Cancer, 2013. 108(1): p. 99-106.
45. Li, Y., H.P. Yu, and P. Zhang, CCL15 overexpression predicts poor
prognosis for hepatocellular carcinoma. Hepatol Int, 2016. 10(3): p.
488-92.
46. Akram, I.G., et al., The chemokines CCR1 and CCRL2 have a role in
colorectal cancer liver metastasis. Tumour Biol, 2016. 37(2): p.
2461-71.